Page last updated: 2024-08-23

substance p and Heart Defects, Congenital

substance p has been researched along with Heart Defects, Congenital in 1 studies

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (100.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Bush, A; Collins, P; Kelleher, A; Li, J; Morgan, C; Penny, DJ; Redington, AN; Rigby, ML; Schulze-Neick, I; Shinebourne, EA1

Other Studies

1 other study(ies) available for substance p and Heart Defects, Congenital

ArticleYear
L-arginine and substance P reverse the pulmonary endothelial dysfunction caused by congenital heart surgery.
    Circulation, 1999, Aug-17, Volume: 100, Issue:7

    Topics: Administration, Inhalation; Arginine; Cardiopulmonary Bypass; Endothelium, Vascular; Heart Defects, Congenital; Humans; Hypertension, Pulmonary; Infant; Infusions, Intravenous; Nitric Oxide; Oxygen; Postoperative Complications; Pulmonary Circulation; Substance P; Vascular Resistance; Vasodilation; Vasodilator Agents

1999